INTRODUCTION
The mouse uterus is receptive to transferred eggs during the 3rd and 4th days of pregnancy or pseudopregnancy (McLaren & Michie, 1956) , and is maximally sensitive to decidualizing stimuli on the 4th day (Finn, 1965) . The receptive period is prolonged by lactation, and by ovariectomy in early pregnancy, fol¬ lowed by progesterone treatment; implantation can then be induced at any time by the injection of oestrogen (Whitten, 1955; Yoshinaga & Adams, 1966 ).
The present work was undertaken to determine if progestagen treatment of cyclic mice would similarly render their uteri receptive so that subsequent sensitization could be controlled by exogenous oestrogen. If so, mice prepared in this way could be used as recipients for egg transfers, obviating the need to induce pseudopregnancy by mating with vasectomized males.
MATERIALS AND METHODS
Sensitization was tested by the injection of 0-02 ml air into the left uterine horn about 7 hr after the injection of oestrogen, or by the transfer of morulae or blastocysts (usually six per mouse) from donor mice 3 i days post coitum 24 hr before oestrogen injection of recipient mice. Deciduomata were assessed 3 to 4 days after the injection of air: mice with swellings in the left horn were con¬ sidered to have responded, and the difference in weight between the two horns was taken as an estimate of the size of the response. Implantation of transferred eggs was assessed at laparotomy 6 days after transfer, and fetal survival was examined at autopsy 10 days later (i.e. at term). At autopsy, ovaries were checked for CL and weighed, and some were examined histologically.
Hormones were injected subcutaneously: 6a-methyl-17a-acetoxyprogesterone (MAP, medroxyprogesterone acetate; Depoprovera, Upjohn) in 0-05 ml vehicle; 1 mg 17a-acetoxy-6-methyl-16-methylene pregna-4,6-diene-3,20-dione (melengestrol acetate, MGA; Upjohn) in 0-1 ml of 2% methyl cellulose; and oestradiol-17/? (Koch-Light) in 0-1 ml arachis oil. Since the proportion of transferred eggs represented by swellings was similar with 2-5, 5-0 and 7-5 mg MAP, a standard dose of 2-5 mg was used. For oestradiol, 6 ng and 15 ng gave a similar response, but 37-5 ng gave a lower response than either (P<0-01) : 15 ng oestradiol was therefore adopted as a standard dose.
Virgin, cyclic 6-to 9-week-old female mice of the 0_strain were used. When MAP was given during oestrus and oestradiol and air were injected 2 to 5 days later, the proportion of mice responding depended on the interval (P<0-05) but the size of the response did not vary significantly (Table 2) . A 4-day interval gave the highest proportion of mice responding and also the largest deciduomata. The probability of deciduoma induction was not related to the presence of active (i.e. red) CL at the time of air injection or at autopsy, nor was any correlation found between the decidual response and ovarian Everett, 1966) . The proportion of eggs that implant following transfer to pseudopregnant rats varies with the hormonal method of induction used (Banik & Ketchel, 1965; Mantalenakis & Ketchel, 1966) . The latter workers found that injection of MAP at oestrus and metoestrus was as effective a method for the induction of pseudopregnancy as mating with vasectomized males, in terms of the propor¬ tion of transferred eggs developing to fetuses. In the present study, the most suitable scheme both for the induction of deciduomata and for fetal develop¬ ment after egg transfer was the injection of MAP (or MGA) during oestrus followed by the injection of oestradiol 4 days later. Pro-oestrus was the only other cycle stage when an injection of MAP allowed the development of some viable full-term fetuses.
The importance of injecting the progestagens during oestrus for subsequent uterine sensitivity suggests that the time of their action relative to the release of pro-oestrous oestrogen is important. This is confirmed by the improvement in subsequent uterine sensitivity after the simultaneous treatment of mice at metoestrus with MAP and 0-5^g oestradiol. The endogenous release of oestro¬ gen during pro-oestrus 'primes' the uterus for subsequent progesterone action during normal pregnancy and pseudopregnancy. Weichert (1928) first demon¬ strated that deciduomata could be induced in ovariectomized rats given 'corpus luteum extract' after oestrogen priming. Priming with oestrogen has since been demonstrated to be necessary for maximal deciduoma formation in ovariecto¬ mized rats (see review by De Feo, 1967) and mice (Finn, 1966) treated with progesterone. With regard to the implantation of transferred eggs, the situation is less clear, since Humphrey (1969) found that oestrogen priming in ovariecto¬ mized mice did not lead to any significant increase in the number of eggs implanting.
In the present experiments, the 4-day MAP-oestradiol interval between the progestagen injection and the sensitizing dose of oestradiol gave the best results for deciduoma induction (Table 2 ) and egg transfer ( (Finn, 1966; Humphrey, 1969) .
It is probable that the treatment of intact cyclic mice with progestagens did not abolish endogenous oestrogen release. Survival of fetuses to term was rare in mice ovariectomized on the 6th to 8th day of pregnancy and treated with MAP unless daily oestradiol was also given (Grant, 1972) yet, in the present work, full fetal development occurred in mice with no CL at autopsy. Further, MAP injected on the 1st day of pregnancy delayed implantation in rats (Barnes & Meyer, 1964; Nutting & Soliman, 1967) but not in mice (Grant, 1972) , sug¬ gesting that release of the oestrogen required for implantation was not inhibited in mice.
Fetal survival was lower when MAP was given during pro-oestrus and after the 5-day MAP-oestradiol interval than when MAP (or MGA) was given at oestrus with the 4-day interval (see Tables 3 and 4 The disadvantage of the hormonal method from the point ofview of providing egg-transfer recipients is that it requires events to be precisely timed in relation to the oestrous cycle in order to induce maximum uterine sensitivity. This requirement probably reflects both the influence of oestrogen at pro-oestrus, in setting the time limits for subsequent uterine sensitivity, and the release of endogenous oestrogen which could interfere with sensitivity induced by exo¬ genous oestrogen. Treatment with MAP seems less effective in suppressing gonadotrophin release in mice than in rats and this may be one reason why MAP did not induce pseudopregnancy in mice.
